| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Pyxis Oncology, Inc. (PYXS) has 0 insiders with recent SEC Form 4 filings, including 9 buys and 5 sells. PYXS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 26, 2024 | Connealy Pamela Ann73 | CFO &COO | Buy | 88,850 | $1.96 | $174,364.00 | +4.0% | -31.6% | +198.3% | |
| Sep 28, 2023 | Connealy Pamela Ann73 | CFO And COO | Buy | 8,000 | $1.87 | $14,960.00 | +1.0% | -14.7% | +77.5% | |
| Sep 27, 2023 | Wadhane Jitendra72 | Chief Accounting Officer | Buy | 2,500 | $1.87 | $4,675.00 | +1.1% | -5.4% | +102.2% | |
| Sep 27, 2023 | Connealy Pamela Ann73 | CFO And COO | Buy | 6,426 | $1.85 | $11,867.54 | +0.8% | -5.4% | +102.2% | |
| Sep 25, 2023 | Wadhane Jitendra72 | Chief Accounting Officer | Buy | 5,000 | $1.77 | $8,850.00 | +2.3% | -2.2% | +102.2% | |
| Sep 25, 2023 | Connealy Pamela Ann73 | CFO And COO | Buy | 12,000 | $1.67 | $20,043.60 | +1.5% | -2.2% | +102.2% | |
| Sep 22, 2023 | Wadhane Jitendra72 | Chief Accounting Officer | Buy | 2,500 | $1.74 | $4,349.25 | +1.2% | +4.4% | +130.6% | |
| Sep 22, 2023 | Connealy Pamela Ann73 | CFO And COO | Buy | 5,000 | $1.74 | $8,695.00 | +0.6% | +4.4% | +130.6% | |
| Sep 18, 2023 | Sullivan Lara | President And CEO | Sell | 8,641 | $2.10 | $18,161.10 | -0.2% | -14.7% | +77.0% | |
| Sep 13, 2023 | Sullivan Lara | President And CEO | Sell | 27,917 | $2.27 | $63,300.82 | -0.4% | -24.1% | +62.5% |